PL3199145T3 - Stabilizowana formulacja preparatu kwasu foliowego/żelaza - Google Patents

Stabilizowana formulacja preparatu kwasu foliowego/żelaza

Info

Publication number
PL3199145T3
PL3199145T3 PL16153154T PL16153154T PL3199145T3 PL 3199145 T3 PL3199145 T3 PL 3199145T3 PL 16153154 T PL16153154 T PL 16153154T PL 16153154 T PL16153154 T PL 16153154T PL 3199145 T3 PL3199145 T3 PL 3199145T3
Authority
PL
Poland
Prior art keywords
folic acid
stabilized formulation
iron preparation
iron
preparation
Prior art date
Application number
PL16153154T
Other languages
English (en)
Inventor
Kerstin BERGMANN
Doris Lechner
Christof WACHTER
Harald Wagner
Heimo WINKLER
Original Assignee
G.L. PHARMA GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by G.L. PHARMA GmbH filed Critical G.L. PHARMA GmbH
Publication of PL3199145T3 publication Critical patent/PL3199145T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL16153154T 2016-01-28 2016-01-28 Stabilizowana formulacja preparatu kwasu foliowego/żelaza PL3199145T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16153154.6A EP3199145B1 (de) 2016-01-28 2016-01-28 Stabilisierte formulierung eines folsäure/eisen-präparats

Publications (1)

Publication Number Publication Date
PL3199145T3 true PL3199145T3 (pl) 2019-06-28

Family

ID=55300357

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16153154T PL3199145T3 (pl) 2016-01-28 2016-01-28 Stabilizowana formulacja preparatu kwasu foliowego/żelaza

Country Status (3)

Country Link
EP (1) EP3199145B1 (pl)
HU (1) HUE040694T2 (pl)
PL (1) PL3199145T3 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115040489B (zh) * 2022-08-17 2022-10-25 北京罗诺强施医药技术研发中心有限公司 具有优良一致性的稳定药物组合物及其制法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945083A (en) * 1986-06-03 1990-07-31 Jansen Jr Christian J Safe oral folic-acid-containing vitamin preparation
US6352713B1 (en) 1999-12-01 2002-03-05 Drugtech Corporation Nutritional composition
US6521247B1 (en) * 1999-08-13 2003-02-18 Warner Chilcott Laboratories Ireland Limited Dual iron containing nutritional supplement
DE10357277A1 (de) * 2003-12-05 2005-06-30 Phyt-Immun Gmbh Mittel zur Verbesserung der Eisenaufnahme
US20090035385A1 (en) * 2004-12-22 2009-02-05 Drugtech Corporation Compositions including iron
DE102005011029A1 (de) 2005-03-08 2006-09-14 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die perorale Applikation mit gesteuerter Freisetzung von Wirkstoffen
DE102008046650A1 (de) 2008-09-10 2010-03-11 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Quetiapin enthaltende Retardtablette
DE102009013612A1 (de) 2009-03-17 2010-09-23 Ratiopharm Gmbh Retigabin-Tabletten, bevorzugt mit modifizierter Freisetzung
WO2011107921A2 (en) 2010-03-04 2011-09-09 Ranbaxy Laboratories Limited Modified release composition of milnacipran
CN103998024A (zh) 2011-12-22 2014-08-20 勃林格殷格翰国际有限公司 速释多单元微丸系统
CA2879603A1 (en) 2012-07-27 2014-01-30 Ratiopharm Gmbh Oral dosage forms for modified release comprising ruxolitinib

Also Published As

Publication number Publication date
EP3199145B1 (de) 2018-10-17
EP3199145A1 (de) 2017-08-02
HUE040694T2 (hu) 2019-03-28

Similar Documents

Publication Publication Date Title
ZA202001037B (en) Novel orally administrable formulation
HK1248570A1 (zh) D2o穩定化的藥物製劑
HK1256195A1 (zh) 穩定的抗ifnar1配製品
IL246447B (en) A pharmaceutical preparation containing a pyridylaminoacetic acid compound
GB201421163D0 (en) Formulations of metal complexes
GB201522764D0 (en) Formulations of phosphate derivatives
IL262233B (en) Meters drug of consequence of amino acid
HK1249068A1 (zh) 小檗碱製劑的治療用途
PL3134070T3 (pl) Kompozycje poliortoestru i kwasu organicznego jako substancji pomocniczej
LT3430004T (lt) Nilotinibo druskų kietosios būsenos formos
IL263155A (en) Combination formulation of three antiviral compounds
IL267279A (en) Pharmaceutical formulations of suvorexant
HUE040694T2 (hu) Folsav/vas-készítmény stabilizált kiszerelése
IL262351B (en) Methods for the production of nutritional formulations
HUP1600415A2 (en) Pimavanserin salts for the manufacture of pharmaceutical formulations
GB201417646D0 (en) Formulations of phosphate derivatives